The October 2019 action authorizes the manufacturer to market these specific products with the claim Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. In a modified risk tobacco product application (MRTPA) review, FDA generally must look at whether the applicant has demonstrated that the product as actually used by consumers will significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole
What the STAKE Act Requires No sale, gift, or transfer of tobacco products to anyone under 21 Photo ID verification for any customer who appears under 21 (most enforcement guides say check anyone who looks under 27) A 1-800 warning sign posted at every point of sale, at least 5.5 inches by 5.5 inches Cooperation with random undercover decoy inspections by youth purchasers STAKE Act Civil Penalties Senate Bill 1230 raised civil penalties for selling tobacco to a minor
A June 11 th American Cancer Society policy paper (here) states that the Society will focus on the primary goal of ending deadly combustible tobacco use Given this imperative, ACS will provide smokers and the public with clear and accurate information available on the absolute and relative health impact of combustible tobacco products, nicotine-based medications, [electronic nicotine delivery systems] and other novel tobacco productsACS will increase its efforts to guide smokers toward evidence-based cessation options that enable them to quit as quickly as possible and eliminate their exposure to combustible tobacco smoke. ACS researchers have estimated the number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States (available here)
La cigarette lectronique, un produit inoffensif , vraiment
Patches require daily replacement, and continual use should not exceed eight to 12 weeks without conferring with a medical professional
